develop
realtim
revers
transcriptionpcr
rtpcr
method
detect
respiratori
virus
infl
uenza
viru
b
respiratori
syncyti
viru
rsv
subgroup
b
parainfl
uenza
viru
piv
adenoviru
rhinoviru
rv
enteroviru
coronaviru
human
metapneumoviru
hmpv
human
bocaviru
hbov
new
method
detect
virus
appli
simultan
realtim
pcr
detect
six
bacteri
pathogen
clinic
sampl
pediatr
patient
communityacquir
pneumonia
cap
patient
suspect
singl
bacteri
infect
multipl
bacteri
infect
coinfect
bacteria
virus
singl
viral
infect
multipl
viral
infect
remain
etiolog
unknown
breakdown
suspect
caus
pathogen
follow
streptococcu
pneumonia
mycoplasma
pneumonia
haemophilu
infl
uenza
chlamydophila
pneumonia
breakdown
virus
follow
rv
rsv
hmpv
piv
hbov
new
method
contribut
advanc
accuraci
diagnosi
also
result
appropri
use
antimicrobi
communityacquir
pneumonia
cap
common
infecti
diseas
occur
children
etiolog
agent
vari
includ
number
virus
bacteria
streptococcu
pneumonia
haemophilu
infl
uenza
mycoplasma
pneumonia
chlamydophila
pneumonia
select
appropri
antimicrobi
patient
bacteri
pneumonia
identifi
cation
caus
pathogen
quickli
fi
rst
day
hospit
would
extrem
use
possibl
would
also
decreas
hospit
cost
length
stay
construct
simultan
identifi
cation
system
use
realtim
pcr
assay
laboratori
six
main
bacteri
pathogen
clinic
sampl
collect
pediatr
patient
cap
subsequ
method
improv
ad
multiplex
pcr
mpcr
kit
seven
virus
total
time
requir
obtain
result
virus
h
use
improv
method
detect
etiolog
agent
patient
hospit
cap
studi
antibodi
titer
pathogen
also
measur
pair
sera
patient
verifi
pcr
result
base
identifi
cation
etiolog
agent
case
studi
categor
viral
infect
viral
bacteri
coinfect
bacteri
infect
pneumonia
infect
includ
coinfect
anoth
pathogen
c
pneumonia
infect
data
similar
previous
report
michelow
et
al
et
al
well
known
caus
virus
respiratori
tract
infect
rti
quit
vari
infl
uenza
virus
b
flu
flu
b
respiratori
syncyti
viru
rsv
subgroup
b
parainfl
uenza
viru
adenoviru
adv
rhinoviru
rv
enteroviru
ev
coronaviru
cov
human
metapneumoviru
hmpv
human
bocaviru
hbov
also
report
recent
etiolog
agent
cap
recent
realtim
reversetranscriptionpcr
rtpcr
method
appli
identifi
cation
respiratori
virus
pcr
method
appear
sensit
cultur
less
affect
specimen
qualiti
transport
provid
object
interpret
result
unit
state
food
drug
administr
clear
market
test
call
xtag
respiratori
viral
panel
luminex
moleoular
diagnost
toronto
canada
simultan
detect
identifi
es
respiratori
virus
method
detect
virus
within
h
use
realtim
rtpcr
routin
method
diagnosi
focus
develop
method
cover
detect
respiratori
virus
within
h
combin
method
previous
describ
method
detect
six
main
bacteri
pathogen
involv
cap
articl
describ
result
obtain
comprehens
identifi
cation
system
realtim
pcr
appli
clinic
sampl
collect
pediatr
patient
cap
total
nasopharyng
swab
sampl
sent
laboratori
pediatrician
ten
medic
institut
particip
acut
respiratori
diseas
ard
studi
group
januari
decemb
sampl
collect
pediatr
patient
cap
age
year
cap
diagnos
presenc
pulmonari
infi
ltrate
chest
xray
inform
consent
obtain
patient
parentsguardian
blood
sampl
determin
wbc
creactiv
protein
crp
serum
antibodi
titer
sever
pathogen
nasopharyng
swab
sampl
determin
caus
pathogen
realtim
pcr
collect
applic
form
patient
name
doctor
name
withheld
written
doctor
charg
sent
laboratori
clinic
sampl
patient
durat
symptom
day
visit
hospit
patient
alreadi
administ
intraven
antibiot
anoth
hospit
clinic
exclud
studi
count
without
reserv
consider
percentag
viru
posit
appar
drop
lower
valu
nasopharyng
sampl
suspend
ml
pleuropneumonialik
organ
pplo
broth
difco
detroit
mi
usa
immedi
receiv
pplo
broth
select
cultiv
pneumonia
aliquot
pplo
broth
transfer
eppendorf
tube
centrifug
rpm
min
nine
hundr
microlit
supernat
discard
remain
solut
includ
pellet
use
sampl
dnarna
extract
use
extragen
ii
tosoh
tokyo
japan
accord
manufactur
protocol
follow
fi
rst
aliquot
suspens
transfer
eppendorf
tube
contain
deterg
dnarna
coprecipit
next
eppendorf
tube
vortex
mixtur
volvol
isopropanolcontain
proteindenatur
deterg
ad
result
mixtur
centrifug
rpm
min
vortex
supernat
discard
residu
treat
volvol
isopropanol
describ
final
harvest
dna
rna
pellet
resuspend
dnaseand
rnasefre
h
provid
dnarna
sampl
extract
process
fi
nish
within
min
cdna
synthesi
revers
transcript
rt
perform
eppendorf
tube
contain
reaction
mixtur
addit
aliquot
dnarna
sampl
describ
reaction
mixtur
consist
u
rever
tra
ace
toyobo
osaka
japan
ii
mm
dntp
iii
random
primer
iv
u
rnase
inhibitor
v
rt
buffer
rt
reaction
carri
min
min
termin
incub
min
use
thermal
cycler
gene
amp
pcr
system
perkinelm
cetu
norwalk
ct
usa
rt
reaction
dw
ad
tabl
show
four
set
virusspecifi
c
primer
molecular
beacon
mb
probe
rsv
subgroup
b
adv
cov
hbov
newli
construct
studi
primer
mb
adenoviru
probe
modifi
ed
jiang
order
amplifi
serotyp
hbov
cov
primer
design
base
align
nation
center
biotechnolog
inform
ncbi
databas
refer
sequenc
follow
hbov
access
cov
access
probe
slightli
modifi
ed
mb
probe
previous
describ
follow
refer
rsv
subgroup
flu
flu
b
rv
ev
hmpv
mb
probe
primer
prepar
sigmaaldrich
japan
tokyo
japan
operon
biotechnolog
tokyo
japan
respect
mb
probe
label
fl
uoresc
report
uorescein
fam
carboxyxrhodamin
rox
end
label
black
hole
quencher
end
reaction
mixtur
consist
realtim
pcr
master
mix
toyobo
primer
mb
probe
fi
nal
volum
mixtur
adjust
addit
dnaseand
rnasefre
h
multiplex
reaction
rsv
subgroup
subgroup
b
perform
mix
set
primer
mb
probe
realtim
rtpcr
reaction
mixtur
one
well
contain
reaction
mixtur
rsv
subgroup
subgroup
b
correspond
virus
perform
pcr
plate
bio
medic
equip
tokyo
japan
eight
sampl
one
assay
well
arrang
one
strip
one
sampl
plate
store
use
prior
amplifi
cation
cdna
ad
well
ice
amplifi
cation
immedi
start
fi
rst
step
follow
cycl
pcr
use
stratagen
la
jolla
ca
usa
thermal
cycler
dice
takara
bio
kyoto
japan
realtim
pcr
fi
nish
within
h
total
time
sampl
disposit
fi
nish
h
less
sensit
realtim
rtpcr
determin
test
tenfold
serial
dilut
tissu
cultur
infecti
dose
tcid
titrat
stock
solut
follow
virus
rsv
subgroup
rsv
subgroup
b
flu
adv
cov
threshhold
cycl
ct
valu
everi
dilut
viru
determin
duplic
pcr
test
limit
detect
ct
valu
viru
follow
tcid
ml
cycl
rsv
subgroup
tcid
ml
cycl
rsv
subgroup
b
tcid
ml
cycl
flu
tcid
ml
cycl
tcid
ml
cycl
tcid
ml
cycl
adv
tcid
ml
cycl
cov
result
limit
ct
valu
estim
posit
correspond
viru
defi
ned
fewer
amplifi
cation
cycl
specifi
citi
mb
probe
primer
set
virus
cycl
amplifi
cation
shown
tabl
nonspecifi
c
posit
result
obtain
virus
select
random
laboratori
stock
cdna
specifi
citi
primer
probe
high
sensit
specifi
citi
realtim
rtpcr
also
compar
result
obtain
mpcr
kit
respiratori
infect
associ
virus
maximbio
san
francisco
ca
usa
design
identifi
seven
virus
name
rsv
flu
flu
b
adv
one
tube
reaction
perform
accord
manufactur
protocol
use
cdna
sensit
specifi
citi
realtim
rtpcr
rel
convent
pcr
seven
virus
respect
data
shown
six
pathogen
pneumonia
h
infl
uenza
pneumonia
c
pneumonia
pyogen
legionella
pneumophila
identifi
ed
use
realtim
pcr
respiratori
tract
infect
rti
kit
code
takara
bio
kyoto
japan
describ
previous
total
time
dna
extract
fi
nish
h
bacteri
cultur
speci
identifi
cation
perform
accord
manual
clinic
microbiolog
result
etiolog
agent
tabl
show
etiolog
agent
found
cap
patient
visit
hospit
within
day
symptom
onset
mean
day
etiolog
classif
made
accord
tent
criteria
describ
nakayama
et
al
singl
bacteri
infect
identifi
ed
n
patient
multipl
bacteri
infect
identifi
ed
n
mix
infect
bacteria
virus
identifi
ed
n
singl
viral
infect
identifi
ed
n
multipl
viral
infect
identifi
ed
n
infect
etiolog
agent
unknown
occur
n
patient
examin
tabl
show
bacteria
suspect
caus
pathogen
differenti
whether
singl
infect
coinfect
bacteri
infect
account
n
case
among
n
caus
pneumonia
n
caus
pneumonia
n
caus
h
infl
uenza
n
caus
c
pneumonia
n
caus
pyogen
case
caus
pathogen
suspect
pneumonia
h
infl
uenza
c
pneumonia
half
singl
infect
other
mostli
show
coinfect
virus
contrast
pneumonia
infect
case
mostli
singl
infect
tabl
show
identifi
ed
viral
pathogen
viral
infect
account
n
case
cumul
posit
case
determin
realtim
rtpcr
show
rv
account
n
viral
infect
rsv
n
hmpv
n
piv
n
hbov
n
adv
n
remain
virus
flu
flu
b
cov
ev
combin
other
tabl
percentag
singl
viral
infect
rel
higher
rsv
hmpv
piv
rv
hbov
distribut
pathogen
agent
accord
age
tabl
show
distribut
pathogen
agent
identifi
ed
accord
patient
age
median
age
patient
infect
pneumonia
h
infl
uenza
year
respect
median
age
infect
pneumonia
c
pneumonia
year
respect
median
age
patient
posit
infect
rsv
hbov
adv
rang
year
median
age
posit
infect
rv
hmpv
piv
slightli
higher
wbc
count
crp
determin
patient
day
sampl
collect
pcr
tabl
show
median
valu
rang
wbc
count
crp
patient
bacteri
infect
bacteri
viral
coinfect
viral
infect
patient
pneumonia
h
infl
uenza
infect
bacteri
viral
coinfect
median
valu
compar
high
mm
wbc
mgdl
crp
contrast
valu
patient
pneumonia
c
pneumonia
infect
appar
low
mm
mm
respect
wbc
mgdl
mgdl
respect
crp
patient
infect
pyogen
ev
cov
includ
median
valu
wbc
count
crp
patient
posit
virus
mm
less
mgdl
less
respect
except
adv
rsv
detect
mainli
august
januari
correspond
late
summer
winter
season
although
number
small
flu
detect
februari
march
winter
season
account
piv
case
predomin
may
juli
spring
summer
season
rv
detect
month
year
peak
incid
observ
august
septemb
hmpv
peak
predominantli
februari
juli
earli
spring
summer
hbov
detect
may
june
antimicrobi
resist
pneumonia
h
infl
uenza
pneumonia
cap
pose
major
clinic
problem
treatment
patient
therapeut
antibiot
administ
patient
upon
hospit
usual
select
empir
base
like
etiolog
agent
view
chest
xray
hematolog
studi
consider
histori
respiratori
symptom
age
patient
avoid
inappropri
antimicrobi
therapi
select
appropri
agent
guidelin
cap
pediatr
adult
patient
propos
japan
well
countri
howev
often
encount
patient
diffi
cult
predict
caus
pathogen
clinic
fi
nding
describ
prefer
etiolog
agent
identifi
ed
day
hospit
diagnosi
cap
made
without
wait
bacteri
cultur
recent
realtim
pcr
pneumonia
c
pneumonia
l
pneumophila
caus
pneumonia
realtim
pcr
respiratori
virus
receiv
attent
effect
method
detect
identifi
etiolog
agent
accur
children
cap
necessari
improv
comprehens
pcr
detect
bacteria
virus
one
sampl
order
lighten
load
patient
improv
costeffect
describ
method
section
import
characterist
examin
protocol
includ
laborsav
procedur
extract
dna
rna
clinic
sampl
use
extragen
ii
kit
tosoh
took
less
min
extract
sampl
divid
use
realtim
pcr
bacteri
detect
realtim
rtpcr
viral
detect
realtim
pcr
result
etiolog
agent
obtain
within
h
time
receipt
clinic
sampl
recent
improv
method
cdna
synthesi
use
new
enzym
primescript
rtase
takarabio
tokyo
japan
synthesi
fi
nish
min
accordingli
result
bacteri
viral
analysi
realtim
pcr
obtain
within
h
present
improv
method
appli
laboratori
examin
expect
could
contribut
greatli
use
appropri
antimicrobi
chemotherapi
note
sputum
collect
rather
difficult
children
compar
adult
nasopharyng
sampl
commonli
use
realtim
pcr
children
although
nasopharyng
sampl
appropri
identifi
virus
pneumonia
c
pneumonia
specimen
alway
appropri
detect
pneumonia
h
infl
uenza
bacteria
often
isol
nasopharyng
site
healthi
control
well
posit
result
bacteria
obtain
realtim
pcr
care
evalu
whether
infect
case
whether
result
refl
ect
presenc
indigen
bacteria
although
wbc
crp
valu
may
provid
use
inform
determin
etiolog
agent
cap
studi
necessari
construct
appropri
indic
previous
report
nakayama
et
al
higher
percentag
patient
pcrposit
pneumonia
c
pneumonia
virus
show
significantli
high
antibodi
titer
correspond
pathogen
word
pcr
result
turn
posit
may
determin
target
caus
agent
present
studi
percentag
case
h
infl
uenza
suspect
caus
pathogen
appar
higher
studi
assum
refl
ect
situat
h
infl
uenza
type
b
hib
vaccin
avail
period
studi
hib
vaccin
howev
approv
japanes
ministri
health
labor
welfar
distribut
japan
hmpv
hbov
newli
identifi
ed
etiolog
agent
caus
cap
includ
realtim
pcr
detect
system
virus
realtim
pcr
use
pathogenspecifi
cmb
probe
anneal
inner
portion
amplifi
ed
dna
product
appar
improv
specifi
citi
assay
compar
convent
pcr
data
shown
although
well
known
rsv
piv
main
caus
virus
cap
patient
compar
high
rate
hmpv
hbov
shown
result
section
notabl
studi
epidem
due
hmpv
may
occur
studi
period
age
peak
rsv
hbov
infect
year
old
less
hmpv
slightli
higher
addit
prevail
virus
differ
depend
season
may
serv
good
refer
determin
cap
caus
virus
final
anticip
realtim
rtpcr
develop
multiplex
onestep
method
order
establish
rapid
comprehens
system
identifi
cation
virus
bacteria
